IP Library Granted Patent US 9,370,588
Granted Patent B2
US 9,370,588 · App. 13/839,791 · Granted Jun 21, 2016

Luciferin amides

Inventor: Stephen C. Miller (Cambridge, MA)
Assignee: University of Massachusetts
A61K49/0045A61K49/0021C07D277/66C07D513/04G01N21/763A61K49/0017
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,370,588
App. No.
13/839,791
Granted
Jun 21, 2016
Kind
B2
Abstract

This disclosure relates to luciferin amides of formula (I) shown below: Each variable in formula (I) is defined in the specification. These compounds can be used to detect fatty acid amide hydrolase activities in vitro, in live cells, or in vivo.

Claims (45)

1. A compound of formula (I):

wherein

n is 0;

is deleted;

each of X 1 and X 2 is S;

each of Y 1 and Y 2 is N;

Z is C(R c ) or C(R c R c′ ), in which each of R c and R c′ , independently, is H or C 1 -C 10 alkyl; provided that, when is a single bond, Z is C(R c R c′ ) and that, when is a double bond, Z is C(R c );

each of R 1 , R 4 , R 5 , and R 6 , independently, is H, halo, CN, OR e , SR e , NO 2 , N(R e R e′ ), C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 20 cycloalkyl, C 3 -C 20 cycloalkenyl, C 1 -C 20 heterocycloalkyl, C 1 -C 20 heterocycloalkenyl, aryl, heteroaryl, in which each of R e and R e′ , independently, is H or C 1 -C 10 alkyl;

R 2 and R 3 , together with the carbon atoms to which they are attached, are a 5 or 6-membered ring, each of which is optionally substituted with C 1 -C 10 alkyl or optionally fused with a 5 or 6-membered ring; and

each of R 7 and R 8 , independently, is H, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 20 cycloalkyl, C 3 -C 20 cycloalkenyl, C 1 -C 20 heterocycloalkyl, C 1 -C 20 heterocycloalkenyl, aryl, or heteroaryl.

2. The compound of claim 1 , wherein R 2 and R 3 , together with the carbon atoms to which they are attached, are a 5-membered ring optionally substituted with CH 3 , or a 6-membered ring optionally substituted with CH 3 or optionally fused with a 5-membered ring.

3. The compound of claim 2 , wherein each of R 1 and R 4 , independently, is H, OH, or C 1 -C 10 alkyl.

4. The compound of claim 3 , wherein each of R 5 and R 6 is H and each of R 7 and R 8 , independently, is H or C 1 -C 10 alkyl.

5. The compound of claim 4 , wherein the compound is

6. The compound of claim 1 , wherein the compound is a D-isomer.

7. An imaging method, comprising:

contacting a cell comprising a luciferase and a fatty acid amide hydrolase with the compound of claim 1 ; and

detecting bioluminescent emission from the cell.

8. The method of claim 7 , wherein the luciferase is a wild-type luciferase.

9. The method of claim 8 , wherein the wild-type luciferase is a beetle luciferase.

10. The method of claim 9 , wherein the beetle luciferase is a firefly, click beetle, or railroad worm luciferase.

11. The method of claim 7 , wherein the luciferase is a mutated luciferase.

12. The method of claim 7 , wherein the contacting step is performed in a brain of a subject.

13. An imaging method, comprising:

contacting a cell comprising a fatty acid amide hydrolase with the compound of claim 1 ;

introducing a luciferase; and

detecting bioluminescent emission.

14. A compound of formula (I):

wherein

n is 0;

is deleted;

each of X 1 and X 2 is S;

each of Y 1 and Y 2 is N;

Z is C(R c ) or C(R c R c′ ), in which each of R c and R c′ , independently, is H or C 1 -C 10 alkyl; provided that, when is a single bond, Z is C(R c R c′ ) and that, when is a double bond, Z is C(R c );

each of R 1 , R 4 , R 5 , and R 6 , independently, is H, halo, CN, OR e , SR e , NO 2 , N(R e R e′ ), C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 20 cycloalkyl, C 3 -C 20 cycloalkenyl, C 1 -C 20 heterocycloalkyl, C 1 -C 20 heterocycloalkenyl, aryl, heteroaryl, in which each of R e and R e′ , independently, is H or C 1 -C 10 alkyl;

R 2 and R 3 , together with the carbon atoms to which they are attached, are a 5 or 6-membered ring, each of which is optionally substituted with C 1 -C 10 alkyl or optionally fused with a 5 or 6-membered ring;

R 7 is H, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 20 cycloalkyl, C 3 -C 20 cycloalkenyl, C 1 -C 20 heterocycloalkyl, C 1 -C 20 heterocycloalkenyl, aryl, or heteroaryl; and

R 8 is C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 20 cycloalkyl, C 3 -C 20 cycloalkenyl, C 1 -C 20 heterocycloalkyl, C 1 -C 20 heterocycloalkenyl, aryl, or heteroaryl.

15. An imaging method, comprising:

contacting a cell comprising a luciferase and a fatty acid amide hydrolase with the compound of claim 14 ; and

detecting bioluminescent emission from the cell.

16. An imaging method, comprising:

contacting a cell comprising a fatty acid amide hydrolase with the compound of claim 14 ;

introducing a luciferase; and

detecting bioluminescent emission.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2013
From: MILLER, STEPHEN C.
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 030140/0569 →
Continuity (2)
Provisional Application 61749139 · Jan 4, 2013
Related Publication 20140193340A1 · Jul 10, 2014